• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

mirnome 分析揭示了饮食诱导的非酒精性脂肪性肝病发病机制中的新的分子决定因素。

Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease.

机构信息

Unit of Metabolic and Autoimmune Liver Diseases, Bambino Gesù Children's Hospital and Research Institute, Rome, Italy.

出版信息

Lab Invest. 2011 Feb;91(2):283-93. doi: 10.1038/labinvest.2010.166. Epub 2010 Oct 18.

DOI:10.1038/labinvest.2010.166
PMID:20956972
Abstract

Nonalcoholic fatty liver disease (NAFLD) is an emerging disease with a broad spectrum of liver conditions. The complex molecular pathogenesis of NAFLD is still unclear. In this study, we conducted an analysis of microRNA (miRNA) expression profiles in liver of rats made NAFLD by different diets. To this aim, Sprague-Dawley rats were fed ad libitum for 3 months with different diets: standard diet (SD), diet enriched in fats and low in carbohydrates (HFD), SD with high fructose (SD-HF) and diet with high levels of fats and fructose (HFD-HF). Our results demonstrated that the treatment with different dietetic regimens caused a significant increase of the body weight and the alteration of some metabolic parameters compared with control animals, as well as various liver injuries. The miRNAs analysis showed the significant downregulation of three miRNAs (miR-122, miR-451 and miR-27) and the upregulation of miR-200a, miR-200b and miR-429 in HFD, SD-HF and HFD-HF rats. Besides, miR-21 expression was significantly decreased only in fructose-enriched diets. These miRNAs target molecules involved in the control of lipid and carbohydrate metabolism, signal transduction, cytokine and chemokine-mediated signaling pathway and apoptosis. Western blot analysis of PKCδ, LITAF, ALDOLASE-A, p38MAPK, PTEN, LIPIN1, EPHRIN-A1, EPHA2 and FLT1 showed a diet-induced deregulation of all these proteins. Interestingly, the expression pattern of LITAF, PTEN, LIPIN1, EPHRIN-A1, EPHA2 and FLT1 might be well explained by the trend of their specific mRNAs, by potentially regulatory miRNAs, or both. In conclusion, we highlight for the first time the potential involvement of novel determinants (miRNAs and proteins) in the molecular pathogenesis of diet-induced NAFLD.

摘要

非酒精性脂肪性肝病 (NAFLD) 是一种具有广泛肝脏疾病谱的新兴疾病。NAFLD 的复杂分子发病机制尚不清楚。在这项研究中,我们对不同饮食导致的 NAFLD 大鼠肝脏中 microRNA (miRNA) 表达谱进行了分析。为此,我们让 Sprague-Dawley 大鼠自由进食 3 个月,给予不同的饮食:标准饮食 (SD)、高脂肪低碳水化合物饮食 (HFD)、SD 加高果糖 (SD-HF) 和高脂肪高果糖饮食 (HFD-HF)。我们的结果表明,与对照动物相比,不同饮食方案的治疗导致体重显著增加和一些代谢参数改变,以及各种肝损伤。miRNA 分析显示,HFD、SD-HF 和 HFD-HF 大鼠中三种 miRNA(miR-122、miR-451 和 miR-27)显著下调,miR-200a、miR-200b 和 miR-429 上调。此外,仅在富含果糖的饮食中 miR-21 的表达显著降低。这些 miRNA 的靶分子参与脂质和碳水化合物代谢、信号转导、细胞因子和趋化因子介导的信号通路以及细胞凋亡的调控。PKCδ、LITAF、ALDOLASE-A、p38MAPK、PTEN、LIPIN1、EPHRIN-A1、EPHA2 和 FLT1 的 Western blot 分析显示,这些蛋白质均受到饮食诱导的调控。有趣的是,LITAF、PTEN、LIPIN1、EPHRIN-A1、EPHA2 和 FLT1 的表达模式可能很好地解释了它们特定 mRNA 的趋势、潜在的调节 miRNA,或两者兼而有之。总之,我们首次强调了新的决定因素(miRNA 和蛋白质)在饮食诱导的 NAFLD 分子发病机制中的潜在作用。

相似文献

1
Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease.mirnome 分析揭示了饮食诱导的非酒精性脂肪性肝病发病机制中的新的分子决定因素。
Lab Invest. 2011 Feb;91(2):283-93. doi: 10.1038/labinvest.2010.166. Epub 2010 Oct 18.
2
Chaihu Shugan powder influences nonalcoholic fatty liver disease in rats in remodeling microRNAome and decreasing fatty acid synthesis.柴胡疏肝散通过重塑微小RNA组和减少脂肪酸合成来影响大鼠非酒精性脂肪性肝病。
J Ethnopharmacol. 2024 Jan 10;318(Pt A):116967. doi: 10.1016/j.jep.2023.116967. Epub 2023 Jul 26.
3
Redox homeostasis and posttranslational modifications/activity of phosphatase and tensin homolog in hepatocytes from rats with diet-induced hepatosteatosis.肝细胞中氧化还原稳态和磷酸酶张力蛋白同源物的翻译后修饰/活性与饮食诱导的脂肪性肝病大鼠相关。
J Nutr Biochem. 2012 Feb;23(2):169-78. doi: 10.1016/j.jnutbio.2010.11.013. Epub 2011 Mar 30.
4
Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications.非酒精性脂肪性肝病(NAFLD)或非酒精性脂肪性肝炎(NASH)细胞模型中细胞内和细胞外微小RNA组失调:临床意义
Nutr Metab Cardiovasc Dis. 2016 Dec;26(12):1129-1139. doi: 10.1016/j.numecd.2016.08.004. Epub 2016 Aug 20.
5
Aberrant hepatic microRNA expression in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中肝脏微小RNA表达异常
Cell Physiol Biochem. 2014;34(6):1983-97. doi: 10.1159/000366394. Epub 2014 Nov 26.
6
Effect of Chronic Western Diets on Non-Alcoholic Fatty Liver of Male Mice Modifying the PPAR-γ Pathway via miR-27b-5p Regulation.慢性西方饮食通过 miR-27b-5p 调控 PPAR-γ 通路对雄性小鼠非酒精性脂肪肝的影响。
Int J Mol Sci. 2021 Feb 12;22(4):1822. doi: 10.3390/ijms22041822.
7
Fatty liver is associated with transcriptional downregulation of stearoyl-CoA desaturase and impaired protein dimerization.脂肪肝与硬脂酰辅酶 A 去饱和酶的转录下调和蛋白二聚化受损有关。
PLoS One. 2013 Sep 30;8(9):e76912. doi: 10.1371/journal.pone.0076912. eCollection 2013.
8
Beraprost sodium, a prostacyclin analogue, reduces fructose-induced hepatocellular steatosis in mice and in vitro via the microRNA-200a and SIRT1 signaling pathway.贝前列素钠,一种前列环素类似物,通过微小RNA - 200a和SIRT1信号通路减轻果糖诱导的小鼠肝细胞脂肪变性及体外肝细胞脂肪变性。
Metabolism. 2017 Aug;73:9-21. doi: 10.1016/j.metabol.2017.05.003. Epub 2017 May 11.
9
Comparison of dietary control and atorvastatin on high fat diet induced hepatic steatosis and hyperlipidemia in rats.饮食控制与阿托伐他汀对高脂饮食诱导的大鼠肝脂肪变性和高脂血症的比较。
Lipids Health Dis. 2011 Jan 26;10:23. doi: 10.1186/1476-511X-10-23.
10
Aberrant expression of microRNA induced by high-fructose diet: implications in the pathogenesis of hyperlipidemia and hepatic insulin resistance.高果糖饮食诱导的微小RNA异常表达:对高脂血症和肝脏胰岛素抵抗发病机制的影响。
J Nutr Biochem. 2017 May;43:125-131. doi: 10.1016/j.jnutbio.2017.02.003. Epub 2017 Feb 20.

引用本文的文献

1
The use of circulating miRNAs for the diagnosis, prognosis, and personalized treatment of MASLD.循环微小RNA在非酒精性脂肪性肝病的诊断、预后及个性化治疗中的应用
J Physiol Biochem. 2025 Jul 16. doi: 10.1007/s13105-025-01110-w.
2
Involvement of miRNAs in the Cluster of Metabolic Factors of MetS: Nutrition-Genome-MetS Axis.微小RNA在代谢综合征代谢因子簇中的作用:营养-基因组-代谢综合征轴
J Clin Med. 2025 Jun 14;14(12):4234. doi: 10.3390/jcm14124234.
3
miRNA-642a-3p protects β cells from glucolipotoxicity.微小RNA-642a-3p可保护β细胞免受糖脂毒性作用。
Mol Ther Nucleic Acids. 2025 Mar 25;36(2):102498. doi: 10.1016/j.omtn.2025.102498. eCollection 2025 Jun 10.
4
Fructose-induced progression of steatohepatitis involves disrupting aldolase B-AMPK signaling in methionine adenosyltransferase 1A deficient mice.在蛋氨酸腺苷转移酶1A缺陷小鼠中,果糖诱导的脂肪性肝炎进展涉及破坏醛缩酶B-AMPK信号通路。
Metabolism. 2025 Apr;165:156154. doi: 10.1016/j.metabol.2025.156154. Epub 2025 Feb 6.
5
Metformin's effect on metabolic dysfunction-associated steatotic liver disease through the miR-200a-5p and AMPK/SERCA2b pathway.二甲双胍通过miR-200a-5p和AMPK/SERCA2b途径对代谢功能障碍相关脂肪性肝病的影响。
Front Pharmacol. 2024 Dec 17;15:1477212. doi: 10.3389/fphar.2024.1477212. eCollection 2024.
6
Dietary Epigenetic Modulators: Unravelling the Still-Controversial Benefits of miRNAs in Nutrition and Disease.膳食表观遗传调节剂:揭开 miRNA 在营养与疾病中仍具争议的益处之谜。
Nutrients. 2024 Jan 3;16(1):160. doi: 10.3390/nu16010160.
7
Role of microRNA in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a comprehensive review.miRNA 在非酒精性脂肪性肝病 (NAFLD) 和非酒精性脂肪性肝炎 (NASH) 中的作用:全面综述。
J Int Med Res. 2023 Sep;51(9):3000605231197058. doi: 10.1177/03000605231197058.
8
Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease.瘦型非酒精性脂肪性肝病中的表观遗传调控。
Int J Mol Sci. 2023 Aug 16;24(16):12864. doi: 10.3390/ijms241612864.
9
Dietary Supplementation with 20-Hydroxyecdysone Ameliorates Hepatic Steatosis and Reduces White Adipose Tissue Mass in Ovariectomized Rats Fed a High-Fat, High-Fructose Diet.用20-羟基蜕皮酮进行膳食补充可改善高脂高果糖饮食喂养的去卵巢大鼠的肝脂肪变性并减少白色脂肪组织质量。
Biomedicines. 2023 Jul 23;11(7):2071. doi: 10.3390/biomedicines11072071.
10
Ephrin-Eph receptor tyrosine kinases for potential therapeutics against hepatic pathologies.用于治疗肝脏疾病的潜在疗法的 Ephrin-Eph 受体酪氨酸激酶
J Cell Commun Signal. 2023 Sep;17(3):549-561. doi: 10.1007/s12079-023-00750-1. Epub 2023 Apr 27.